bendamustine hydrochloride has been researched along with Myelodysplastic Syndromes in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, MA; da Cunha-Bang, C; Frederiksen, H; Grønbaek, K; Hjalgrim, H; Niemann, CU; Rostgaard, K; Rotbain, EC | 1 |
| Bar, MH; Bartlett, NL; Cabanillas, F; Chen, Z; Cheson, BD; Dodds, AJ; Ellis, T; Friedberg, JW; Ganjoo, KN; Herst, J; Joyce, R; LaCasce, AS; Lemieux, B; Leonard, JP; Martin, P; Montgomery, PG; Pressnail, B; Rajguru, SA; Robinson, KS; Smith, MR; Szer, J; van der Jagt, RH; VanderWalde, A; Williams, M | 1 |
| Hiraga, J; Kagami, Y; Narita, M; Suzuki, N; Takagi, Y; Tomita, A | 1 |
| Appelbaum, FR; Becker, PS; Boehm, A; Dean, C; Deeg, HJ; Estey, EH; Hendrie, PC; Lionberger, JM; Mawad, R; Ostronoff, F; Pagel, JM; Sandhu, VK; Scott, BL; Shadman, M; Shannon-Dorcy, K; Walter, RB; Xie, H | 1 |
| Bauer, K; Brillant, C; Engert, A; Herbst, C; Kluge, S; Monsef, I; Skoetz, N | 1 |
| Borthakur, G; Chacar, C; Cortes, J; Estrov, Z; Jabbour, E; Kadia, T; Kantarjian, H; Ravandi, F; Rios, MB | 1 |
| Gattermann, N; Germing, U; Haas, R; Hartmann, J; Knipp, S; Strupp, C | 1 |
2 trial(s) available for bendamustine hydrochloride and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Outpatient bendamustine and idarubicin for upfront therapy of elderly acute myeloid leukaemia/myelodysplastic syndrome: a phase I/II study using an innovative statistical design.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cohort Studies; Female; Hospitalization; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Nitrogen Mustard Compounds; Outpatients; Treatment Outcome | 2014 |
Phase I-II study of bendamustine in patients with acute leukemia and high risk myelodysplastic syndrome.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Female; Humans; Leukemia; Male; Middle Aged; Myelodysplastic Syndromes; Nitrogen Mustard Compounds; Treatment Outcome; Young Adult | 2012 |
5 other study(ies) available for bendamustine hydrochloride and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Risk of new malignancies among patients with CLL treated with chemotherapy: results of a Danish population-based study.
Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Chlorambucil; Cohort Studies; Denmark; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Myelodysplastic Syndromes; Neoplasms, Second Primary; Registries; Risk Assessment; Survival Analysis; Vidarabine | 2021 |
Long-term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non-Hodgkin lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Clinical Trials as Topic; Disease-Free Survival; Female; Hematopoietic Stem Cell Mobilization; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multicenter Studies as Topic; Myelodysplastic Syndromes; Neoplasms, Second Primary; Rituximab; Time Factors; Treatment Outcome | 2017 |
Partial restoration of CD20 protein expression and rituximab sensitivity after treatment with azacitidine in CD20-negative transformed diffuse large B cell lymphoma after using rituximab.
Topics: Antigens, CD20; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bendamustine Hydrochloride; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fatal Outcome; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Molecular Targeted Therapy; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednisone; Rituximab; Vincristine | 2018 |
Eleventh biannual report of the Cochrane Haematological Malignancies Group: Focus on Hodgkin lymphoma.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bendamustine Hydrochloride; Bleomycin; Chlorambucil; Controlled Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Exercise; Hematinics; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Multicenter Studies as Topic; Myelodysplastic Syndromes; Nitrogen Mustard Compounds; Prednisone; Procarbazine; Quality of Life; Randomized Controlled Trials as Topic; Vinblastine; Vincristine | 2010 |
A pilot study of bendamustine in elderly patients with high-risk MDS and AML.
Topics: Acute Disease; Aged; Antineoplastic Agents; Bendamustine Hydrochloride; Drug Evaluation; Female; Humans; Leukemia, Myeloid; Male; Myelodysplastic Syndromes; Nitrogen Mustard Compounds; Pilot Projects | 2007 |